Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Irisbiosciences a New Player in 3D Cell Culture

Published: Friday, February 14, 2014
Last Updated: Friday, February 14, 2014
Bookmark and Share
Irisbiosciences is focused on the development, manufacturing and marketing of products for bio-/pharmaceutical research and development, namely 3D cell culture products, tissue models and human & stem cells for in-vitro experimentation.

Company premises include a GMP facility with clean rooms (Classes A, C and D) and the company operates 250 m2 of fully equipped BSL Level 2, R&D, Analytical and QC laboratories for development of medical devices and tissue engineering products. 

irisbiosciences provides 3D cell culture products , as well as contract research and manufacturing services in cell based essays and cell based products. 


mimsys® for 3D Cell culture 
mimsys® G is a xeno-free and non-immunogenic hydrogel, easy to handle, for cell encapsulation in 3D experiments in vitro or in vivo. mimsys® G is nutrient permeable and allows long term 3D cell culture, at least 21 days of proliferation and survival. The transparency of mimsys® G hydrogel make it suitable for established laboratorial cell assays, such as cell differentiation, microscopy evaluations, viability protocols and histological procedures. Protocol handbook is available upon request. 

Human Mesenchymal Stem Cells 
High quality and high purity mesenchymal stem cells are obtained from human adipose tissue. These cells can be applied in a broad range of basic and applied research contexts. Tissue processing, cell isolation and cryopreservation are performed under Good Manufacturing Practices (cGMP), using xeno-free and GMP reagents. Cells have very low levels of manipulation which minimizes genomic instability. Frozen vials are provided with indication of donor age, gender, ethnicity, Body Mass Index (BMI) and anatomical harvesting location. Protocol handbook is available upon request. 


Contract Research 
irisbiosciences provides contract research services on medical device and advanced therapy medicinal products, by encompassing experimental development, in vitro performance assessment and in vivo testing. Our skill set includes strong competence in biomaterials’ development and cell culturing technologies, and extensive knowledge and experience in tissue engineering and regenerative medicine. 

irisbiosciences provides: 

  • Biomaterials development and testing; 
  • Cell based assays development and validation; 
  • Cell isolation and cell manipulation protocol development; 
  • Development and testing of cell based products. 

Contract Manufacturing Services : 

irisbiosciences provides a wide range of cGMP services concerning human tissue, cells and related products, including tissue processing, manufacturing of cell-based products, as well as cell manufacturing and banking. 

The facility comprises 250 m2 of qualified controlled environment rooms (CERs), or clean rooms, and material pass-throughs. The CERs are designed to maximize environmental quality, allow the manufacturing of sterile products and are compliant with all the requirements of the European Union Tissue and Cells Directives (EUTCD) and the guidelines for cGMP.To insure the highest levels of quality and regulatory compliance, we have implemented and follow a complete Quality System in conformity with EU-GMP Guide/ICH Q7 and ISO 9001:2008. 

irisbiosciences performs a comprehensive range of analytical testing to ensure product quality and demonstrate the control of viable and non-viable particles, in all irisbiosciences CERs associated with the aseptic preparation process. Quality control tests include LAL test for bacterial endotoxin quantification; mycoplasma detection by conventional PCR, and microbial contaminants detection / Sterility tests. For detection of microbial contaminants, irisbiosciences is equipped with Bact/ALERT Microbial Detection System requirements. 

Our Facilities/Equipment description: 

  • 6 cGMP compliant cleanroom areas; 
  • 3 Grade C/ISO 7 manufacturing rooms fitted with aseptic Isolators with positive pressure; 
  • 1 Grade D/ISO 8 support room and cryostorage room; 
  • 2 HVAC systems for continuity of processing; 
  • Dedicated clean room and facility monitoring system; 
  • Dedicated manufacturing room for cell expansion; 
  • O2 and CO2 controlled incubation. 

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos